Comparison of the fluoroquinolones based on pharmacokinetic and pharmacodynamic parameters.
about
In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses.Antibiotics in the treatment of acute exacerbations of chronic bronchitis.Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 2: human trials.A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitisMicrobiological analysis of a prospective, randomized, double-blind trial comparing moxifloxacin and clindamycin in the treatment of odontogenic infiltrates and abscessesLevofloxacin pharmacokinetics in adult cystic fibrosis.Fluoroquinolone antibiotics having the potential to interfere with fluorescence-based diagnosis.Pharmacological rationale for antibiotic treatment of intra-abdominal infections.Pharmacological and pharmaeconomic considerations.Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones.Pharmacokinetics of intravenous finafloxacin in healthy volunteers.Phosphine-Initiated General-Base-Catalyzed Quinolone Synthesis.Permeability classification of representative fluoroquinolones by a cell culture method.Pharmacological properties of oral antibiotics for the treatment of uncomplicated urinary tract infections.
P2860
Q34251731-A83292E9-9D2E-4137-BD68-4628CE95D50BQ34706968-D9265E05-9C54-40AD-9338-8492E6101293Q35547236-1C2E8543-0D6C-4009-A2E8-FBC03CF0AB2FQ35591290-C77B03C7-F647-4FDD-B094-8E4AD1ABFA4DQ35941373-B02C445C-87F9-47DF-A239-B934BCB418EAQ36137356-FDCC4ADD-4126-4CFF-90CF-363569FC248EQ37008961-1274BE44-56F3-44C3-9EBE-F6EB65FBBB93Q37557851-7CC6F844-3A1D-4FF9-8226-0A973F6B4728Q37811606-189E2B10-F761-4CDA-A95A-E076971ACEA4Q38040734-F792B4DC-996C-47B5-B0D5-F9096375175AQ38636236-52E2800A-74D1-4C07-B41D-983C1A63C1A1Q42142495-BB512D7D-981D-4C52-A53D-E3BC08F3F6A8Q46369508-178735FA-5269-4476-B6CB-5D88D89485E2Q54296506-E080EEB5-046E-4269-8196-898479175085
P2860
Comparison of the fluoroquinolones based on pharmacokinetic and pharmacodynamic parameters.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Comparison of the fluoroquinol ...... nd pharmacodynamic parameters.
@ast
Comparison of the fluoroquinol ...... nd pharmacodynamic parameters.
@en
type
label
Comparison of the fluoroquinol ...... nd pharmacodynamic parameters.
@ast
Comparison of the fluoroquinol ...... nd pharmacodynamic parameters.
@en
prefLabel
Comparison of the fluoroquinol ...... nd pharmacodynamic parameters.
@ast
Comparison of the fluoroquinol ...... nd pharmacodynamic parameters.
@en
P2093
P2860
P1433
P1476
Comparison of the fluoroquinol ...... nd pharmacodynamic parameters.
@en
P2093
Paladino JA
Pickerill KE
Schentag JJ
P2860
P304
P356
10.1592/PHCO.20.5.417.35062
P407
P577
2000-04-01T00:00:00Z